Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

'Yumanity Therapeutics Patent App #20220298168 Published For "Compounds Useful In The Treatment Of Neurological Disorders" Target Alzheimer's' - U.S. Patent & Trademark Office

Author: Benzinga Newsdesk | September 28, 2022 12:39pm

https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PG01&s1=20220298168&OS=20220298168&RS=20220298168

 

https://twitter.com/US_Patent_Plays/status/1575162691143999489

Posted In: YMTX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist